Alzheimer's Disease
|
0.320 |
Biomarker
|
disease |
BEFREE |
Together, these results highlight the potential contribution of IGF-II receptor to AD pathology not only by regulating expression/processing of APP but also by its role in cellular vulnerability.
|
25939386 |
2015 |
Parkinson Disease
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
While PD-linked point mutant Vps35 D620N interacts with the cation-independent mannose-6-phosphate receptor (CI-M6PR), a known retromer cargo, we find that its expression disrupts the trafficking of cathepsin D, a CI-M6PR ligand and protease responsible for degradation of α-synuclein, a causative agent of PD.
|
24152121 |
2014 |
Parkinson Disease
|
0.320 |
Biomarker
|
disease |
CTD_human |
Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.
|
19276553 |
2009 |
Prostatic Neoplasms
|
0.320 |
GeneticVariation
|
group |
LHGDN |
Loss of heterozygosity of M6P/IGF2R gene is an early event in the development of prostate cancer.
|
16304558 |
2006 |
Alzheimer's Disease
|
0.320 |
Biomarker
|
disease |
CTD_human |
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
|
15750215 |
2005 |
Alzheimer's Disease
|
0.320 |
Biomarker
|
disease |
LHGDN |
Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease.
|
15167696 |
2004 |
Prostatic Neoplasms
|
0.320 |
Biomarker
|
group |
LHGDN |
Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells.
|
12586773 |
2003 |
Ventricular Dysfunction
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Overexpression of IGF-IIRα regulates cardiac remodeling and aggravates high salt induced apoptosis and fibrosis in transgenic rats.
|
30450786 |
2019 |
Endomyocardial Fibrosis
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Overexpression of IGF-IIRα regulates cardiac remodeling and aggravates high salt induced apoptosis and fibrosis in transgenic rats.
|
30450786 |
2019 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Lung diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
Prenatal administration of retinoic acid upregulates insulin-like growth factor receptors in the nitrofen-induced hypoplastic lung.
|
21433279 |
2011 |
Congenital diaphragmatic hernia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Prenatal administration of retinoic acid upregulates insulin-like growth factor receptors in the nitrofen-induced hypoplastic lung.
|
21433279 |
2011 |
Congenital hernia of foramen of Morgagni
|
0.300 |
Biomarker
|
disease |
CTD_human |
Prenatal administration of retinoic acid upregulates insulin-like growth factor receptors in the nitrofen-induced hypoplastic lung.
|
21433279 |
2011 |
Congenital hernia of foramen of Bochdalek
|
0.300 |
Biomarker
|
disease |
CTD_human |
Prenatal administration of retinoic acid upregulates insulin-like growth factor receptors in the nitrofen-induced hypoplastic lung.
|
21433279 |
2011 |
Lung diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
Insulinlike growth factor receptor type 1 and type 2 are downregulated in the nitrofen-induced hypoplastic lung.
|
20620343 |
2010 |
Congenital diaphragmatic hernia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Insulinlike growth factor receptor type 1 and type 2 are downregulated in the nitrofen-induced hypoplastic lung.
|
20620343 |
2010 |
Congenital hernia of foramen of Morgagni
|
0.300 |
Biomarker
|
disease |
CTD_human |
Insulinlike growth factor receptor type 1 and type 2 are downregulated in the nitrofen-induced hypoplastic lung.
|
20620343 |
2010 |
Congenital hernia of foramen of Bochdalek
|
0.300 |
Biomarker
|
disease |
CTD_human |
Insulinlike growth factor receptor type 1 and type 2 are downregulated in the nitrofen-induced hypoplastic lung.
|
20620343 |
2010 |
Lewy Body Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Brain insulin-like growth factor and neurotrophin resistance in Parkinson's disease and dementia with Lewy bodies: potential role of manganese neurotoxicity.
|
19276553 |
2009 |
Presenile dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
|
15750215 |
2005 |
Familial Alzheimer Disease (FAD)
|
0.300 |
Biomarker
|
disease |
CTD_human |
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
|
15750215 |
2005 |
Alzheimer Disease, Late Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
|
15750215 |
2005 |
Acute Confusional Senile Dementia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
|
15750215 |
2005 |
Alzheimer's Disease, Focal Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
|
15750215 |
2005 |
Alzheimer Disease, Early Onset
|
0.300 |
Biomarker
|
disease |
CTD_human |
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?
|
15750215 |
2005 |